Market Overview
We have two business divisions; Human Care and Animal Care. Within Human Care, our focus for superficial tumours is in the Middle East, Asia, India S-E Asia and Africa, where the needs are great and where there are few alternatives and cost-effective treatment methods. The technology platform has already been launched in several markets and is used at a number of hospitals and cancer centres in India, the Philippines, Malaysia and Kenya. As for deep-seated tumours such as Bone and Pancreatic cancer, we focus on the European and North American markets primarily. The wholly-owned subsidiary Vetiqure AB runs the Animal Care business division and is primarily focused on the markets in Scandinavia, Europe, North America and the Middle East.